Global Cardiac Ablation Market Trajectory & Analytics Report 2022: Market to Reach $1.7 Billion by 2027 - Emerging Markets Forecast to Post High Growth - ResearchAndMarkets.com

The "Cardiac Ablation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Cardiac Ablation Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Cardiac Ablation estimated at US$855.9 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 10.6% over the analysis period 2020-2027.

Radiofrequency (RF) Ablation, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$900.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrical Ablation segment is readjusted to a revised 9.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $415.8 Million, While China is Forecast to Grow at 15.2% CAGR

The Cardiac Ablation market in the U.S. is estimated at US$415.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$125.8 Million by the year 2027 trailing a CAGR of 15.2% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Cryoablation Segment to Record 10.2% CAGR

In the global Cryoablation segment, USA, Canada, Japan, China and Europe will drive the 9.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$71.3 Million in the year 2020 will reach a projected size of US$138.3 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$139 Million by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • An Introduction to Cardiac Ablation
  • Types of Cardiac Ablation Technologies
  • Radiofrequency (RF) Ablation
  • Electrical Energy-Based Ablation
  • Cryoablation
  • Ultrasound Energy-Based Ablation
  • Microwave Energy-based Ablation
  • Cardiac Ablation Market: Growth Prospects and Outlook
  • Emerging Markets Forecast to Post High Growth
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 16 Featured)

  • Abbott Laboratories
  • Alcon Laboratories, Inc.
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Medtronic PLC
  • Olympus Corporation

3. MARKET TRENDS & DRIVERS

  • Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Fuel Cardiac Surgical Volumes Fuel Growth in the Cardiac Ablation Market
  • Leading Causes of Mortality for Low-Income and High-Income Countries
  • Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac Ablation Market
  • As Cardiovascular Disease Prevalence Increases at a Strong Rate in Developing Economies, Tremendous Potential Exists for Cardiac Ablation Market
  • Growing Significance of Cardiac Ablation for Cardiac Rhythm Management
  • Rising Incidence of Atrial Fibrillation: An Opportunity for Cardiac Ablation Market
  • Ranking of Factors for Incidence of Atrial Fibrillation
  • Innovative Technologies Assist in Enhancing AF Ablation Process
  • Ablation Found to be Effective for AF Compared to Medications
  • Ablation Technology for Supra-venticular Tachycardia
  • Shift towards Minimally Invasive Surgeries Fuels Demand for Cardiac Ablation Procedures
  • Minimally Invasive Catheter Ablation Continues to Gain Prominence in Cardiac Procedures
  • RF Ablation Emerges as a Preferred Treatment Option for Cardiac Arrhythmias
  • Cryoablation for Treatment of AF: Minimally Invasive Procedure Favors Adoption
  • MRI-Guided Cardiac Ablation Market
  • Hybrid Ablation Procedure for Treatment of Atrial Fibrillation: Addressing the Limitations of Traditional Treatments
  • Technological Advancements Broaden Adoption of Cardiac Ablation Technology
  • Advanced 3D Electrophysiology Mapping and Imaging Systems
  • Cryoballoon Ablation Catheters
  • Laser Balloon Ablation Catheters
  • Contact-Force Technology

4. GLOBAL MARKET PERSPECTIVE

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/9iuilv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.